Press release
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Strategic Insights Driving Denosumab Market Momentum in 2025
Denosumab
How Large Will the Denosumab Market Size By 2025?
The market for denosumab has seen significant expansion in recent times. The growth is expected to rise from $3.27 billion in 2024 to $3.67 billion in 2025, portraying a compound annual growth rate (CAGR) of 12.1%. The increase during the historic period can be accredited to factors like advancements in clinical trials and research, FDA approvals and regulatory milestones, heightened awareness about bone health, along with strategic collaborations and marketing efforts.
How Big Is the Denosumab Market Size Expected to Grow by 2029?
The market size of denosumab is predicted to experience a significant increase in the upcoming years, expanding to "$5.48 billion in 2029 with a 10.6% compound annual growth rate (CAGR). The expected growth during the forecast timeframe can be due to factors such as an increasing occurrence of bone metastases, improved cancer treatments, prevalence of osteoporosis, heightened awareness about osteoporosis, and the approval of regulations for new indications. Notable trends during the forecast period could involve strategic alliances and associations, digital health solutions integration, broadened indications and clinical uses, and enhancements in the development of biosimilars.
View the full report here:
https://www.thebusinessresearchcompany.com/report/denosumab-global-market-report
Which Key Market Drivers Powering Denosumab Market Expansion and Growth?
The denosumab market is projected to grow as osteoporosis becomes more common. Osteoporosis is a health issue characterized by weakened bones, leading to a decrease in bone density and increased risk of fractures. Denosumab helps counteract osteoporosis by halting bone resorption through the RANK ligand's targeting. For example, The National Center for Biotechnology Information, a U.S. government agency, reported in September 2023 that data from the Canadian Longitudinal Study on Aging indicated a 12.7% prevalence of osteoporosis diagnosed by physicians and a 5.9% occurrence of DXA-confirmed osteoporosis among older, community-dwelling females. Furthermore, Buttros and associates completed a cross-sectional research revealing a 24.6% incidence of osteoporosis in postmenopausal women aged 40 to 75, identified via bone mineral density (BMD) measurements. As such, the escalating incidence of osteoporosis is fueling denosumab market growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13835&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Denosumab Market?
Firms with major presence in the denosumab market are focusing more on creating innovative solutions, such as primary treatment options for osteoporosis, in order to maintain a competitive advantage. Initial treatments for osteoporosis are the main therapeutic strategies suggested by healthcare professionals for patients diagnosed with the condition. For example, in November 2022, China's Boan Biotech, a biotech firm, secured approval from the National Medical Products Administration (NMPA) in China for its denosumab biosimilar, Boyoubei, becoming the first company in China to do so. The firm is also working on making this injection available in markets outside China, such as Europe and the United States, with a strategy for global promotion. Various treatment guidebooks have nominated this drug as a primary treatment for osteoporosis. The drug can dramatically reduce the chances of hip, non-vertebral, and vertebral fractures among patients. Moreover, Boyoubei is the first biosimilar to Prolia (the creator of denosumab) to be approved for global marketing.
What Are the Emerging Segments in the Denosumab Market?
The denosumab market covered in this report is segmented -
1) By Drug Classification: Prolia, Xgeva, Others
2) By Type: 60 mg, 120 mg
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13835&type=smp
Who Are the Global Leaders in the Denosumab Market?
Major companies operating in the denosumab market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Limited, Mylan N.V., Sandoz International GmbH, Daiichi Sankyo Company Limited, Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Celltrion Inc., Amneal Pharmaceuticals Inc, Cadila Healthcare Limited, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Jubilant Life Sciences Limited, Ajanta Pharma Limited
Which are the Top Profitable Regional Markets for the Denosumab Industry?
North America was the largest region in the denosumab market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the denosumab market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13835
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Strategic Insights Driving Denosumab Market Momentum in 2025 here
News-ID: 4183283 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Denosumab
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: A Key Driver P …
The Denosumab Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Denosumab Market Size and Its Estimated Growth Rate?
The market size of denosumab has seen a fast-paced expansion in the past few years. It is projected to surge from $3.27 billion in…
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Major Factor i …
How Will the Denosumab Market Grow, and What Is the Projected Market Size?
The denosumab market is expected to grow from $3.27 billion in 2024 to $3.7 billion in 2025, at a CAGR of 13.1%. Clinical trials, research advancements, and growing awareness of bone health are key drivers.
The denosumab market is expected to grow rapidly, reaching $5.59 billion by 2029, with a CAGR of 10.9%. This growth is attributed to the…
Denosumab Market Size, Share, Trends, Insights And Forecast To 2033
The Business Research Company recently released a comprehensive report on the Global Denosumab Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The denosumab market size has grown…
Denosumab Market Key Trends, Insights, Analysis 2024-2033: A Comprehensive Repor …
"The new report published by The Business Research Company, titled "" Denosumab Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023…
Denosumab Global Market Analysis, Trends, Growth, Research And Forecast 2033
The denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to clinical trials and research advancements, FDA approvals and regulatory milestones, growing awareness of bone health, strategic partnerships and marketing initiatives.
The denosumab market size is expected to see…
Denosumab Market Report, Size, Share And Analysis 2024-2033
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Denosumab Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing…
